Literature DB >> 8925566

Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery.

Z Q Yan1, T Yokota, W Zhang, G K Hansson.   

Abstract

NO generated by endothelial cells is vasoprotective by antagonizing platelet adhesion and smooth muscle contraction. Since vascular smooth muscle cells (VSMCs) produce NO in response to cytokine stimulation and after arterial injury, we speculated that NO produced by VSMCs could compensate for the loss of endothelium. Using balloon catheter denudation of the rat carotid artery as a model for arterial injury and restenosis, we have evaluated the time course of expression of inducible NO synthase (iNOS) by in situ hybridization and immunohistochemistry and studied the effect of iNOS on platelet adhesion and blood flow of the injured vessel. iNOS mRNA and protein were expressed in the innermost layer of the media from day 1 and were subsequently detected in the neointima, whereas no expression was detectable in the uninjured artery. Systemic administration of N omega-nitro-L-arginine methyl ester (L-NAME) resulted in a twofold to threefold increase in the adhesion of 111In-labeled platelets to the injured vessel wall. Platelet adhesion was also enhanced threefold by local delivery of L-NAME from a gel surrounding the injured vessel, whereas the stereoisomer, D-NAME, had no effect. Finally, inhibition of NO synthase led to a 24% reduction of the blood flow in the injured carotid artery. These results demonstrate that arterial injury triggers the expression of iNOS in the lesion and that NO produced by iNOS inhibits platelet adhesion and restores blood flow. This could explain the disappearance of platelet thrombi from deendothelialized arterial surfaces within a few days after injury and indicates the importance of NO generated by iNOS for the maintenance of vascular tone. Thus, expression of iNOS in lesions may represent a protective mechanism that compensates for the loss of endothelium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8925566     DOI: 10.1161/01.res.79.1.38

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

Review 1.  Antithrombotic strategies in gene therapy.

Authors:  K M Channon; B H Annex
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

2.  Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.

Authors:  R D Rudic; E G Shesely; N Maeda; O Smithies; S S Segal; W C Sessa
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB.

Authors:  De-xiu Bu; Anne-Louise Hemdahl; Anders Gabrielsen; Jonas Fuxe; Chaoyong Zhu; Per Eriksson; Zhong-qun Yan
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta.

Authors:  Chi Ming Wong; Chak Leung Au; Suk Ying Tsang; Chi Wai Lau; Xiaoqiang Yao; Zongwei Cai; Arthur Chi-Kong Chung
Journal:  Br J Pharmacol       Date:  2017-02-27       Impact factor: 8.739

5.  Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair.

Authors:  De-xiu Bu; Maria E Johansson; Jingyi Ren; Da-wei Xu; F Brad Johnson; Kristina Edfeldt; Zhong-qun Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-23       Impact factor: 8.311

6.  Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.

Authors:  Zachary W Q Moore; David Y Hui
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

7.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Antithrombotic activity of TNF-alpha.

Authors:  Beatrice Cambien; Wolfgang Bergmeier; Simin Saffaripour; Heather A Mitchell; Denisa D Wagner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Pathogenesis of hemorrhagic disease caused by elephant endotheliotropic herpesvirus (EEHV) in Asian elephants (Elephas maximus).

Authors:  Thunyamas Guntawang; Tidaratt Sittisak; Varankpicha Kochagul; Saralee Srivorakul; Kornravee Photichai; Kittikorn Boonsri; Thittaya Janyamethakul; Khajohnpat Boonprasert; Warangkhana Langkaphin; Chatchote Thitaram; Kidsadagon Pringproa
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  Role of arginase in vessel wall remodeling.

Authors:  William Durante
Journal:  Front Immunol       Date:  2013-05-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.